Biotech Values

[stockbettor]

NKTR: Opdivo + 214 trial in sarcoma

An intriguing recent update to this trial in the CT.gov listing. When asked about the trial progress on a recent webcast (I do not recall which one), Howard Robin responded that the release of information was at the discretion of the investigators since this is an IS trial. Nothing has has been provided to date. However, the latest listing shows an increase in the number of anticipated patients from 60 to 100 and the opening of a pediatric arm. Here is a link to a side-by-side comparison of the prior version of the CT listing and the updated listing (a neat new feature added to the CT.gov archive):

https://www.clinicaltrials.gov/ct2/history/NCT03282344?A=5&B=6&C=Side-by-Side